vancomycin-resistant enterococcus

Also found in: Wikipedia.

vancomycin-resistant enterococcus

Infectious disease An enterococcus, primarily Enterococcus faecium, resistant to most antibiotics, including aminoglycosides and vancomycin, once a 'last-resort' agent; VRE is primarily nosocomial, in long hospitalizations–especially in the ICU, enteral feeding, liver transplants, antibiotic-associated colitis; it may be community acquired Management Ampicillin, penicillin G, teicoplanin–not US, quinupristin/dalfopristin or linuzolid, both investigational. See Vancomycin. Cf Methicillin-resistance Staphylococcus aureus.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

van·co·my·cin-re·sis·tant en·ter·o·coc·cus

(VRE) (van'kō-mī'sin-rĕ-zis'tănt en'tĕr-ō-kok'ŭs)
A strain of enterococcial bacteria that resists therapy with vancomycin.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012
References in periodicals archive ?
The researchers found that compared with the 27 months before, during the 36 months following a hospital's move to single-patient rooms, there was an immediate and sustained reduction in nosocomial vancomycin-resistant Enterococcus (VRE) colonization (from 766 to 209 colonizations; incidence rate ratio [IRR], 0.25; 95 percent confidence interval [CI], 0.19 to 0.34) and methicillin-resistant Staphylococcus aureus (MRSA) colonization (from 129 to 112 colonizations; IRR, 0.57; 95 percent CI, 0.33 to 0.96) as well as VRE infection (from 55 to 14 infections; IRR, 0.30; 95 percent CI, 0.12 to 0.75).
Small RNAs in vancomycin-resistant Enterococcus faecium involved in daptomycin response and resistance.
But it found all types of cash had dangerous superbugs MRSA and VRE (Vancomycin-resistant Enterococcus).
Isolation and Biochemical Fingerprinting of Vancomycin-Resistant Enterococcus faecium From Meat, Chicken and Cheese.
Weber, "Prevalence of and risk factors for colonization with vancomycin-resistant Enterococcus among human immunodeficiency virus-positive outpatient," Infection Control and Hospital Epidemiology, vol.
Inhibition of recombinant purified vancomycin-resistant Enterococcus faecium wild-type (A) and C119D (B) MurA by fosfomycin.
Genomic analysis of 495 vancomycin-resistant Enterococcus faecium reveals broad dissemination of a vanA plasmid in more than 19 clones from Copenhagen, Denmark.
coli (Escherichia coli), VRE (Vancomycin-resistant Enterococcus jaecalis) and Enterobacter aerogenes on painted surfaces within two hours of exposure.
The objective of this study was to isolate and characterize bacteriophage against vancomycin-resistant Enterococcus faecalis as a potential agent for VRE control.
coli); Vancomycin-resistant Enterococcus ; Enterococcus faecium; Multidrug-resistant Pseudomonas aeruginosa; and Multidrug-resistant Acinetobacter baumannii.
GlobalData's clinical trial report, "Vancomycin-Resistant Enterococcus Faecium Infections Global Clinical Trials Review, H2, 2015" provides an overview of Vancomycin-Resistant Enterococcus Faecium Infections clinical trials scenario.

Full browser ?